Elsevier

Clinics in Chest Medicine

Volume 21, Issue 4, 1 December 2000, Pages 753-762
Clinics in Chest Medicine

Nutritional Abnormalities and Supplementation in Chronic Obstructive Pulmonary Disease

https://doi.org/10.1016/S0272-5231(05)70182-9Get rights and content

The interest in nutrition in the management of chronic obstructive pulmonary disease (COPD) has increased dramatically during the past two decades. Traditionally, weight loss was considered to be an inevitable and irreversible component of the terminal progression of the disease process. From this viewpoint, it could be argued that nutritional support might actually influence the disease adversely by inducing additional metabolic and ventilatory stress on the respiratory system. Studies demonstrating the disturbed energy balance during weight loss in COPD have, however, challenged this approach. Furthermore, studies taking a more holistic view of COPD, recognizing the irreversible respiratory impairment and the systemic consequences of the disease, revealed that nutritional depletion contributes to respiratory and peripheral skeletal muscle weakness and to decreased exercise performance, independent of impaired lung function. In some patients, this condition is reversible after protein-energy supplementation. Moreover, recent studies have shown that nutritional abnormalities in patients with COPD relate to a disturbed energy balance and to altered regulation of substrate metabolism caused by changes in anabolic and catabolic stimuli. Further characterization and unraveling of these pathophysiologic abnormalities may enlarge the perspective for nutritional intervention, not merely by protein-energy supplementation to reverse weight loss, but also by targeted metabolic modulation of specific problems in subgroups of COPD patients, through nutritive and non-nutritive actions at either physiologic or pharmacologic doses.

Section snippets

PREVALENCE AND CONSEQUENCES OF NUTRITIONAL ABNORMALITIES

To be able to judge the need for and effectiveness of nutritional supplementation as well as understand the optimal nutritional support strategies, it is important to consider the consequences and underlying mechanisms of nutritional abnormalities in COPD. In contrast to fat accumulation as the main concern in obesity, the consequences of weight loss in COPD specifically relate to the decrease in body cell mass (BCM). Body cell mass is defined as the active metabolizing (organs) and contracting

CAUSES OF WEIGHT LOSS AND MUSCLE WASTING

Weight loss and, particularly, loss of fat mass, occurs if energy expenditure exceeds dietary intake. More specifically, muscle wasting is a consequence of an imbalance between protein synthesis and protein breakdown. Impairments in total energy balance and protein metabolism may occur simultaneously, but these processes can also be dissociated because of altered regulation of substrate metabolism. Weight loss in patients with COPD may be caused by altered energy and substrate metabolism

OUTCOME OF NUTRITIONAL INTERVENTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISESASE

The first clinical trials investigating the effectiveness of nutritional intervention consisted of nutritional supplementation by means of oral liquid supplements or enteral nutrition. These short-term studies showed that 2 to 3 weeks of nutritional supplementation lead to a significant increase in body weight and respiratory muscle function.67, 68 The short-term effectiveness noted in these studies is probably partly attributable to repletion of muscle water, electrolytes and cellular energy

Anabolic Agents

The difficulties encountered in trials of nutritional support have led investigators to study alternative methods of inducing weight gain and increases in FFM, in particular, a treatment with recombinant human growth hormone (rhGH). Administration of this hormone induces lipolysis, protein anabolism, and muscle growth, either directly or through insulin-like growth factor (IGF)-1.

Two uncontrolled studies reported the effects of rhGH in nutritionally depleted patients with COPD.44, 60

References (72)

  • A.M.W.J. Schols et al.

    Transcutaneous oxygen saturation and carbon dioxide tension during meals in patients with chronic obstructive pulmonary disease

    Chest

    (1991)
  • Akrabawi SS, Mobarhan S, Ferguson PW: Gastric emptying (GE 1/2) and postprandial resting energy expenditure (REE),...
  • P. Amoroso et al.

    Acute effects of inhaled salbutamol on the metabolic rate of normal subjects

    Thorax

    (1993)
  • E.M. Baarends et al.

    Decreased mechanical efficiency in clinically stable patients with COPD

    Thorax

    (1997)
  • E.M. Baarends et al.

    Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease

    Eur Respir J

    (1997)
  • E.M. Baarends et al.

    Breathing efficiency during inspiratory threshold loading in patients with chronic obstructive pulmonary disease

    Clin Physiol

    (1998)
  • E.M. Baarends et al.

    Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1997)
  • S. Bernard et al.

    Peripheral muscle weakness in patients with chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1998)
  • L. Burdet et al.

    Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study

    Am J Respir Crit Care Med

    (1997)
  • E. Creutzberg et al.

    The influence of an acute disease exacerbation on the metabolic and inflammatory profile in patients with COPD

    Eur Respir J

    (1999)
  • E. Creutzberg et al.

    Characterization of nonresponse to high-caloric oral nutritional therapy in depleted patients with COPD

    Am J Respir Crit Care Med

    (2000)
  • E.C. Creutzberg et al.

    Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects

    Respiration

    (1998)
  • E.C. Creutzberg et al.

    Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function

    Eur J Clin Nutr

    (1998)
  • I. De Godoy et al.

    Elevated-TNF α production by peripheral blood monocytes of weight-losing COPD patients

    Am J Respir Crit Care Med

    (1996)
  • M. Di Francia et al.

    Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1994)
  • M. Donahoe et al.

    The effect of an aggresive support regimen on body composition in patients with severe COPD and weight loss

    Am J Respir Crit Care Med

    (1994)
  • J. Efthimiou et al.

    The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease

    Am Rev Respir Dis

    (1988)
  • J. Engelen et al.

    Different patterns of chronic tissue wasting among emphysema and chronic bronchitis patients

    Clin Nutr

    (1999)
  • M. Engelen et al.

    Skeletal muscle weakness is predominantly the consequence of extremity fat-free mass wasting but not of airflow obstruction in patients with chronic obstructive pulmonary disease

    Am J Clin Nutr

    (2000)
  • M.P.K.J. Engelen et al.

    Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD

    Eur Respir J

    (1994)
  • E. Fiaccadori et al.

    A preliminary report on the effects of malnutrition on skeletal muscle composition in chronic obstructive pulmonary disease

  • C.E. Fuenzalida et al.

    The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease

    Am Rev Respir Dis

    (1990)
  • S.A. Goldstein et al.

    Nitrogen and energy relationships in malnourished patients with emphysema

    Am Rev Respir Dis

    (1988)
  • A. Goris et al.

    Tissue depletion in relation to physical function and quality of life in patients with severe COPD

    Am J Respir Crit Care Med

    (1997)
  • R. Gosselink et al.

    Peripheral muscle weakness contributes to exercise limitation in COPD

    Am J Respir Crit Care Med

    (1996)
  • K. Gray Donald et al.

    Nutritional status and mortality in chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1996)
  • Cited by (81)

    • Respiratory failure treatment

      2018, Medicine (Spain)
    • Advances in chronic obstructive pulmonary disease

      2009, Archivos de Bronconeumologia
    View all citing articles on Scopus

    Address reprint requests to A. M. W. J. Schols, PhD, Department of Pulmonology, University Hospital Maastricht, 6202 AZ Maastricht, Netherlands, e-mail: [email protected]

    *

    Department of Pulmonology, University Hospital Maastricht, Maastricht, Netherlands

    View full text